Literature DB >> 23277084

Causes and consequences of low grade endotoxemia and inflammatory diseases.

Trevor G Glaros1, Samantha Chang, Elizabeth A Gilliam, Urmila Maitra, Hui Deng, Liwu Li.   

Abstract

Increasing clinical observations reveal that persistent low-grade inflammation is associated with the pathogenesis of severe chronic diseases such as atherosclerosis, diabetes, and aging-related neurological diseases. Intriguingly, low levels of circulating Gram-negative bacterial endotoxin lipopolysaccharide (LPS) appear to be one of the key culprits in provoking a non-resolving low-grade inflammation. Adverse life styles, chronic infection, and aging can all contribute to the rise of circulating endotoxin levels and lead to low-grade endotoxemia. As a consequence, low-grade endotoxemia may skew host immune environment into a mild non-resolving pro-inflammatory state, which eventually leads to the pathogenesis and progression of inflammatory diseases. This review aims to highlight the recent progress in the causes and consequences of low-grade endotoxemia, as well as the emerging molecular mechanisms responsible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277084     DOI: 10.2741/s405

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  21 in total

Review 1.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

2.  Genetic basis of age-dependent synaptic abnormalities in the retina.

Authors:  Hitoshi Higuchi; Erica L Macke; Wei-Hua Lee; Sam A Miller; James C Xu; Sakae Ikeda; Akihiro Ikeda
Journal:  Mamm Genome       Date:  2014-10-02       Impact factor: 2.957

3.  Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Authors:  Rosa Zampino; Aldo Marrone; Luca Rinaldi; Barbara Guerrera; Riccardo Nevola; Adriana Boemio; Natalina Iuliano; Mauro Giordano; Nicola Passariello; Ferdinando C Sasso; Emanuele Albano; Luigi E Adinolfi
Journal:  Infection       Date:  2018-07-31       Impact factor: 3.553

4.  Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Soujuan Wang; Zhuo Wang; David L Morris; Carmella Evans-Molina; Raghavendra G Mirmira; Sonia Jancar; C Henrique Serezani
Journal:  Sci Signal       Date:  2015-01-27       Impact factor: 8.192

5.  Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide.

Authors:  Xueqin Chen; Jingyi Tan; Mengqi Yang; Zhi-Kai Liao; Cheng Lu; Youwei Huang; Liang-Cai Wu
Journal:  J Nat Med       Date:  2018-05-14       Impact factor: 2.343

6.  mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.

Authors:  Huanchun Zhang; W Robert Taylor; Giji Joseph; Valentina Caracciolo; Donna M Gonzales; Neil Sidell; Emre Seli; Perry J Blackshear; Caleb B Kallen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

7.  Effect of low-dose corticosterone pretreatment on the production of inflammatory mediators in super-low-dose LPS-primed immune cells.

Authors:  Byeong Suk Chae
Journal:  Toxicol Res       Date:  2020-08-12

8.  Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in Youth.

Authors:  Wei Perng; Jacob E Friedman; Rachel C Janssen; Deborah H Glueck; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

9.  Natural small molecule FMHM inhibits lipopolysaccharide-induced inflammatory response by promoting TRAF6 degradation via K48-linked polyubiquitination.

Authors:  Ke-Wu Zeng; Li-Xi Liao; Hai-Ning Lv; Fang-Jiao Song; Qian Yu; Xin Dong; Jun Li; Yong Jiang; Peng-Fei Tu
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

10.  Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats.

Authors:  Laetitia Rodes; Shyamali Saha; Catherine Tomaro-Duchesneau; Satya Prakash
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.